Overview

With global harmonization of regulatory requirements and quality standards and national and global business consolidations ongoing at a fast pace, pharmaceutical manufacturers, suppliers, contractors, and distributors are impacted by continual change. Offering a wide assortment of policy and guidance document references and interpretations, this Sixth Edition is significantly expanded to reflect the increase of information and changing practices in CGMP regulation and pharmaceutical manufacturing and control practices worldwide. An essential companion for every pharmaceutical professional, this guide is updated and expanded by a team of industry experts, each member with extensive experience in industry or academic settings.

Full Product Details

Author:   Joseph D. Nally (Nallianco LLC, New Vernon, New Jersey, USA)
Publisher:   Taylor & Francis Inc
Imprint:   Informa Healthcare
Edition:   6th New edition
Volume:   169
Dimensions:   Width: 17.80cm , Height: 2.80cm , Length: 25.40cm
Weight:   0.907kg
ISBN:  

9780849339721

ISBN 10:   0849339723
Pages:   424
Publication Date:   26 December 2006
Audience:   College/higher education ,  Undergraduate
Replaced By:   9781498732062
Format:   Hardback
Publisher's Status:   Out of Stock Indefinitely
Availability:   Out of stock  

Table of Contents

Status and Applicability of U.S. Regulations. Finished Pharmaceuticals General Provisions (Subpart A). Organization and Personnel (Subpart B). Buildings and Facilities (Subpart C). Equipment (Subpart D). Control of Components and Drug Product Containers and Closures (Subpart E). Production and Process Controls (Subpart F). Packaging and Labeling Control (Subpart G). Holding and Distribution (Subpart H). Laboratory Controls (Subpart I). Records and Reports (Subpart J). Returned and Salvaged Drug Products (Subpart K). Repacking and Relabeling. Quality Systems and Risk Management Approaches. Clinical Trial Supplies and GMPs. Contracting and Outsourcing. Active Pharmaceutical Ingredients. Bulk Pharmaceutical Excipient GMPs. Recalls, Warning Letter, Seizures and Injunctions: CGMP Enforcement Alternatives in the United States. Controlled Substances Safeguards. The Inspection Procedure for Compliance in the United States: The Regulatee Is Inspected; The Rationale for Inspection. FDA Pre-Approval Inspections/Investigations: The Road from SUPAC to the Food and Drug Modernization Act. Worldwide GMPs. Quality Approaches: ISO 9000, Malcolm Baldrige and Six Sigma. Appendix A: Center for Drug Evaluation and Research (CDER) List of Guidance Documents. Appendix B: ICH Guidelines. Appendix C: FDA / ORA Compliance Policy Guides

Reviews

What is especially valuable about these chapters is the degree of explanation which the authors have brought, and the appropriateness of the examples which they have used. There are ample illustrations....deserves to be read and digested by anyone whose job it is to keep an operation on the proper side of the law. -Pharmaceutical Development and Technology (for fourth edition) The chapters are clearly and concisely written, and provide the reader with the current regulations and practical discussions relating to interpretation of the guidelines.... I am pleased to add this edition to my bookshelf! -European Journal of Pharmaceutics and Biopharmaceutics (for fourth edition) an invaluable text.help[s] any individual or student learn the application of the CGMPs. -Pharmaceutical Research (for fourth edition) excellent in presentation and language.a value to anyone interested in drug manufacture. -American Journal of Pharmaceutical Education (for fourth edition)

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions